C1 esterase inhibitor recombinant Intravenous and Monoclate-P
Determining the interaction of C1 esterase inhibitor recombinant Intravenous and Monoclate-P and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Monoclate-P (human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 esterase inhibitor recombinant Intravenous-Monoclate-P human
- C1 esterase inhibitor recombinant Intravenous-Monodox
- C1 esterase inhibitor recombinant Intravenous-Monoject Prefill Advanced flush
- C1 esterase inhibitor recombinant Intravenous-Monoket
- C1 esterase inhibitor recombinant Intravenous-Mononessa
- C1 esterase inhibitor recombinant Intravenous-Mononine
- Monoclate-P-C1 esterase inhibitor, human Intravenous
- Monoclate-P-C1 Inhibitor (Human)
- Monoclate-P-C1 Inhibitor (Human) (Berinert)
- Monoclate-P-C1 Inhibitor (Human) (Cinryze)
- Monoclate-P-C1 Inhibitor (Human) (Haegarda)
- Monoclate-P-C1 Inhibitor (Recombinant)